-
1 Comment
Al-'Aqar Healthcare REIT is currently in a long term downtrend where the price is trading 2.8% below its 200 day moving average.
From a valuation standpoint, the stock is 29.2% more expensive than other stocks from the Other sector with a price to sales ratio of 8.3.
Al-'Aqar Healthcare REIT's total revenue rose by 53.9% to $41M since the same quarter in the previous year.
Its net income has dropped by 194.0% to $-27M since the same quarter in the previous year.
Finally, its free cash flow grew by 18.6% to $42M since the same quarter in the previous year.
Based on the above factors, Al-'Aqar Healthcare REIT gets an overall score of 2/5.
ISIN | MYL5116TO007 |
---|---|
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
CurrencyCode | MYR |
Exchange | KLSE |
Beta | 0.06 |
---|---|
Market Cap | 1B |
PE Ratio | 18.0 |
Target Price | 1.26 |
Dividend Yield | 5.0% |
Al-`Aqar Healthcare REIT is Malaysia's first Islamic healthcare REIT, listed on the Main Market of Bursa Malaysia in 2006. The REIT comprises 23 properties valued at RM1.64 billion, including 17 hospitals, three wellness centres, two colleges in Malaysia, and an aged care and retirement village in Australia. Al-`Aqar plays a pivotal role in supporting the healthcare infrastructure, with an ambitious goal of achieving an asset value of RM3 billion by 2028. Al-`Aqar actively explores yield-accretive acquisitions from healthcare related assets to enhance future earnings and distributions per unit (DPU).
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 5116.KLSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025